CNBC Earnings

Eli Lilly's stock has been on a tear, driven by positive trial results for its Alzheimer's drug and progress with its promising obesity drug pipeline. 

SoftBank surprised the market with a loss in the first quarter, though its Vision Fund booked a $1.1 billion gain on investments — its first in five quarters.

Paramount Global has agreed to sell Simon & Schuster to private equity giant KKR for $1.62 billion, the company said as it reported quarterly earnings.

Palantir executives say revenue growth will accelerate in the third quarter, reversing a trend from the last several years.

Space infrastructure company Redwire reported second-quarter results Monday, as it nearly erased its net losses.

Lucid's second-quarter revenue fell short of expectations, but a recent cash raise extended the EV maker's runway into 2025.

EVgo's second-quarter results beat Wall Street estimates, as revenue from deals to provide chargers to other businesses surged.

Qualcomm is exposed to the slumping smartphone industry because it makes the processors at the heart of most high-end Android devices.

CVS is cutting costs as it pushes deeper into health-care services after its acquisitions of Signify Health and Oak Street Health.

The results ease investor concerns after Humana and rival UnitedHealth Group warned of a surge in demand for nonurgent surgeries and outpatient services.

Yum Brands restaurant KFC's same-store sales climbed 13%, fueled by demand in China, its largest market.

Sales in the company's second quarter jumped 6% year-over-year, while expenses grew 11%.

Starbucks stock has risen just 1.5% this year, giving the company a market value of $115 billion.

AMD reported an 18% decline in year-over-year revenue in the second quarter and issued a sales forecast that trailed analysts' estimates.

Virgin Galactic flew two spaceflights during the second quarter: Its final test spaceflight and its first commercial spaceflight.

JetBlue Airways slashed its 2023 outlook and warned of a potential loss in the current quarter.

Pfizer is in a transition period as it pivots away from its blockbuster Covid vaccine and drug Paxlovid while the world emerges from the pandemic.

Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.

Shares of Uber fell more than 5% on Tuesday after the company reported second-quarter results that missed analysts' expectations for revenue but offered rosy guidance.

Oil majors have failed to match the bumper profits posted during the same period of last year amid weaker commodity prices.